Bolstered by a recent acquisition, a long-term contract with Walgreens and new hepatitis C products, Chesterbrook-based AmerisourceBergen is riding a wave of record five-year growth, according to a Seeking Alpha report on the company’s stock.

“Three companies generate about 85 to 90 percent of all revenues in the wholesale drug distribution industry: AmerisourceBergen, Cardinal Health, and McKesson Corp., the article stated. “While AmerisourceBergen is not the largest competitor, it does have the best revenue growth.”

Among the highlights was its five-year annual stock growth rate of 12.3 percent and the observation that AmerisourceBergen is well-positioned to capture opportunities in the growing generics, new drug discovery and pharmacy alliance segments.

The company recently acquired MWI Veterinary Supply, inked a 10-year deal with Walgreens in 2013 and launched new hep-C treatments being sold through Gilead Sciences, AbbVie and Johnson & Johnson.

Read more about AmerisourceBergen’s recent stock trends and growth analysis on Seeking Alpha here.